← 返回

纳米药物递送系统在抗肿瘤免疫治疗中的应用

英文原题:Nanodrug Delivery Systems in Antitumor Immunotherapy.

查看英文原题

Nanodrug Delivery Systems in Antitumor Immunotherapy.

PubMed 2024/04/25(内容时间) Biomater Res Q1 · IF 9.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

癌症已成为威胁人类健康最重要的因素之一,全球癌症负担迅速增加。免疫治疗因其高效和预防肿瘤转移而成为继手术、化疗和放疗之后的又一临床研究热点。

然而,免疫治疗在临床应用中存在的免疫缓解率较低和免疫相关不良反应等问题亟待解决。随着纳米药物递送系统的发展,多种纳米载体材料已被用于抗肿瘤免疫治疗的研究,并取得了令人鼓舞的治疗效果。在本综述中,我们主要从以下4个方面总结了纳米药物递送系统与免疫治疗的联合应用:(a) 纳米药物递送系统联合细胞因子治疗以改善细胞因子在体内的递送;(b) 纳米药物递送系统为免疫检查点阻断治疗与其他肿瘤治疗的联合提供了合适的平台;(c) 纳米药物递送系统有助于递送肿瘤疫苗的抗原和佐剂以增强免疫效果;(d) 纳米药物递送系统提高了过继性细胞治疗的治疗效率并降低了毒性。

同时详细介绍了研究人员用于构建纳米药物递送系统的纳米材料及其功能。最后,我们讨论了纳米药物递送系统与免疫治疗联合应用的当前挑战和未来前景。

展开英文摘要原文

Cancer has become one of the most important factors threatening human health, and the global cancer burden has been increasing rapidly. Immunotherapy has become another clinical research hotspot after surgery, chemotherapy, and radiotherapy because of its high efficiency and tumor metastasis prevention.

However, problems such as lower immune response rate and immune-related adverse reaction in the clinical application of immunotherapy need to be urgently solved. With the development of nanodrug delivery systems, various nanocarrier materials have been used in the research of antitumor immunotherapy with encouraging therapeutic results.

In this review, we mainly summarized the combination of nanodrug delivery systems and immunotherapy from the following 4 aspects: (a) nanodrug delivery systems combined with cytokine therapy to improve cytokines delivery in vivo; (b) nanodrug delivery systems provided a suitable platform for the combination of immune checkpoint blockade therapy with other tumor treatments; (c) nanodrug delivery systems helped deliver antigens and adjuvants for tumor vaccines to enhance immune effects; and (d) nanodrug delivery systems improved tumor treatment efficiency and reduced toxicity for adoptive cell therapy.

Nanomaterials chosen by researchers to construct nanodrug delivery systems and their function were also introduced in detail.

Finally, we discussed the current challenges and future prospects in combining nanodrug delivery systems with immunotherapy.

论文信息

作者
Guo Z、Ye J、Cheng X、Wang T、Zhang Y、Yang K、Du S、Li P
单位
Beijing University of Chinese Medicine, Beijing 102488, China.China
文献类型
综述
期刊
Biomaterials research2024
原文标识
PubMed 38840653 · DOI 10.34133/bmr.0015